Home
Scholarly Works
MODELLED IMPACT OF NIRSEVIMAB FOR ALL INFANTS IN...
Conference

MODELLED IMPACT OF NIRSEVIMAB FOR ALL INFANTS IN THE PREVENTION OF RESPIRATORY SYNCYTIAL VIRUS (RSV): RELATED HOSPITALIZATIONS AND ITS PREDICTED COST TO THE BRAZILIAN PUBLIC HEALTHCARE

Authors

Falavigna M; Watanabe SF; Santoro J; Ribeiro K; Tolardo A; Schneider N; Safadi M; Stein RT; Kieffer A

Volume

26

Pagination

pp. S26-S26

Publisher

ELSEVIER SCIENCE INC

Publication Date

December 1, 2023

Conference proceedings

VALUE IN HEALTH

Issue

12

ISSN

1098-3015

Contact the Experts team